Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
CD Protein Inhibitors
>>
Phase 3
1
2
3
»
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
32
64
96
128
160
192
224
256
288
320
Bavencio
(avelumab) / EMD Serono
Jemperli
(dostarlimab-gxly) / GSK
Polivy
(polatuzumab vedotin-piiq) / Roche
spartalizumab
(PDR001) / Novartis
bintrafusp alfa
(M7824) / EMD Serono
Zynyz
(retifanlimab-dlwr) / Incyte
Kymriah
(tisagenlecleucel-T) / Novartis
Bexxar
(iodine I 131 tositumomab) / GSK
Monjuvi
(tafasitamab-cxix) / Incyte
Rituxan Hycela
(rituximab/hyaluronidase) / Biogen, Roche, Halozyme
Columvi
(glofitamab-gxbm) / Roche
balstilimab
(AGEN2034) / Agenus
Epratucyn
(epratuzumab) / Gilead
Lunsumio
(mosunetuzumab-axgb) / Roche, Biogen
ianalumab
(VAY736) / MorphoSys, Novartis
magrolimab
(ONO-7913) / Ono Pharma
retlirafusp alfa
(SHR-1701) / Jiangsu Hengrui Pharma
Pembroria
(pembrolizumab biosimilar) / Biocad
Zynlonta
(loncastuximab tesirine-lpyl) / Overland ADCT BioPharma
ezabenlimab
(BI 754091) / Boehringer Ingelheim
erfonrilimab
(KN046) / Alphamab
ivonescimab
(AK112) / Akesobio, Summit Therap
oleclumab
(MEDI9447) / AstraZeneca
Opdualag
(nivolumab/relatlimab) / BMS, Ono Pharma
Epkinly
(epcoritamab-bysp) / Genmab, AbbVie
Mabtas
(rituximab biosimilar) / Intas
budigalimab
(ABBV-181) / AbbVie
Breyanzi
(lisocabtagene maraleucel) / BMS
Talvey
(talquetamab-tgvs) / J&J
bempegaldesleukin
(NKTR-214) / Nektar Therap, BMS, Ono Pharma
Puyouheng
(pucotenlimab) / Taizhou Hanzhong Biopharma, Lepu Med
Removab
(catumaxomab) / NeoPharm, Trion Pharma
favezelimab/pembrolizumab
(MK-4280A) / Merck (MSD)
volrustomig
(MEDI5752) / AstraZeneca
cetrelimab
(JNJ-63723283) / J&J
sasanlimab
(PF-06801591) / Pfizer
Arenegyr
(NGR-hTNF) / AGC Biologics
Cejemly
(sugemalimab) / CStone Pharma
iparomlimab/tuvonralimab
(PSB205) / Sound Biologics, Qilu Pharma
vibostolimab/pembrolizumab
(MK-7684A) / Merck (MSD)
Lumoxiti
(moxetumomab pasudotox) / AstraZeneca
Nuvion
(visilizumab) / PDL
uproleselan sodium
(APL-106) / GlycoMimetics
utomilumab
(PF-05082566) / Pfizer
BNT327
/ BioNTech
evorpacept
(ALX148) / ALX Oncology
quavonlimab/pembrolizumab
(MK-1308A) / Merck (MSD)
Alzumab
(itolizumab) / Biocon, Equillium, Ono Pharma
nibrozetone
(RRx-001) / EpicentRx
Panvac-VF
(falimarev/inalimarev) / Bavarian Nordic
1
2
3
»
